| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2003PNAS..100.8880W |
| P356 | DOI | 10.1073/PNAS.1533186100 |
| P8608 | Fatcat ID | release_j7fkzkzjrngddl6fbjyog4r2fy |
| P3181 | OpenCitations bibliographic resource ID | 3594192 |
| P932 | PMC publication ID | 166407 |
| P698 | PubMed publication ID | 12840147 |
| P5875 | ResearchGate publication ID | 10679336 |
| P50 | author | Jacek Lubkowski | Q28360195 |
| Wuyuan Lu | Q90908795 | ||
| P2093 | author name string | Zhibin Wu | |
| De Yang | |||
| Joost J Oppenheim | |||
| Cyril Boulègue | |||
| David M Hoover | |||
| Fanny Santamaria | |||
| P2860 | cites work | Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 | Q22010648 |
| Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells | Q22254687 | ||
| Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic | Q24290539 | ||
| Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family | Q24300501 | ||
| Discovery of five conserved beta -defensin gene clusters using a computational search strategy | Q24529856 | ||
| Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria | Q24550625 | ||
| Primary structures of three human neutrophil defensins | Q24563841 | ||
| Defensins. Natural peptide antibiotics of human neutrophils | Q24563852 | ||
| Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity | Q24644524 | ||
| The structure of human beta-defensin-2 shows evidence of higher order oligomerization | Q27625482 | ||
| Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes | Q27630954 | ||
| The structure of human beta-defensin-1: new insights into structural properties of beta-defensins | Q27633872 | ||
| The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus | Q27636772 | ||
| Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization | Q27658909 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Discovery of new human beta-defensins using a genomics-based approach | Q28202377 | ||
| Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction | Q28204611 | ||
| Paneth cells--guardians of the gut cell hatchery | Q28204769 | ||
| Principles that govern the folding of protein chains | Q28236872 | ||
| A peptide antibiotic from human skin | Q28242199 | ||
| Structure, function, and membrane integration of defensins | Q28270856 | ||
| Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils | Q28277848 | ||
| hBD-1: a novel beta-defensin from human plasma | Q28294850 | ||
| Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis | Q28303994 | ||
| Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes | Q33789700 | ||
| Diversity of antimicrobial peptides and their mechanisms of action | Q33789705 | ||
| Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity | Q33789711 | ||
| Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides | Q33789716 | ||
| Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity | Q33789726 | ||
| Innate antimicrobial peptide protects the skin from invasive bacterial infection | Q34102960 | ||
| Defensins of vertebrate animals | Q34109303 | ||
| Structure, function, and inhibition of chemokines | Q34110896 | ||
| Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel | Q34359011 | ||
| Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells | Q34407161 | ||
| Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli | Q34503697 | ||
| [beta]-defensins in lung host defense | Q34516289 | ||
| Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. | Q34732912 | ||
| Paneth cells of the human small intestine express an antimicrobial peptide gene | Q41099931 | ||
| Cationic peptides: a new source of antibiotics | Q41714967 | ||
| Antimicrobial peptides of vertebrates | Q41729805 | ||
| Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues | Q42027179 | ||
| Defensins promote fusion and lysis of negatively charged membranes | Q42843138 | ||
| Interaction of cationic antimicrobial peptides with model membranes | Q43687963 | ||
| Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. | Q46241707 | ||
| Engineered salt-insensitive alpha-defensins with end-to-end circularized structures | Q50122491 | ||
| Design of Salt-Insensitive Glycine-Rich Antimicrobial Peptides with Cyclic Tricystine Structures† | Q57236394 | ||
| Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-β Strand Cystine Knot Framework | Q57236397 | ||
| Membranolytic selectivity of cystine-stabilized cyclic protegrins | Q57236398 | ||
| Mutational Analysis of a Plant Defensin from Radish (Raphanus sativusL.) Reveals Two Adjacent Sites Important for Antifungal Activity | Q61052923 | ||
| In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences | Q67982257 | ||
| A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration | Q72133316 | ||
| Peptide antibiotics | Q73073957 | ||
| Binding of amino acid side-chains to S1 cavities of serine proteinases | Q73104113 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotaxis | Q658145 |
| P304 | page(s) | 8880-5 | |
| P577 | publication date | 2003-07-22 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3 | |
| P478 | volume | 100 |
| Q53250989 | A New, High Yield, Rapid, and Cost-Effective Protocol to Deprotection of Cysteine-Rich Conopeptide, Omega-Conotoxin MVIIA. |
| Q39790103 | A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa. |
| Q27319961 | A novel role for β2-microglobulin: a precursor of antibacterial chemokine in respiratory epithelial cells. |
| Q37393392 | AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense |
| Q51039745 | Alarmin-induced cell migration. |
| Q37404678 | Alarmins and antimicrobial immunity. |
| Q46819070 | Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. |
| Q34463066 | Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines |
| Q30848083 | Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. |
| Q38081821 | Antifungal proteins: More than antimicrobials? |
| Q42244810 | Antimicrobial activities of chemokines: not just a side-effect? |
| Q40013212 | Antimicrobial activity does not predict cytokine response to adrenomedullin or its shortened derivatives |
| Q42700440 | Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on Streptococcus pneumoniae |
| Q35685623 | Antimicrobial characterization of human beta-defensin 3 derivatives |
| Q41348615 | Antimicrobial characterization of site-directed mutagenesis of porcine beta defensin 2. |
| Q45020337 | Antimicrobial efficacy of a human β-defensin-3 peptide using an Enterococcus faecalis dentine infection model |
| Q42275047 | Antimicrobial host defensins - specific antibiotic activities and innate defense modulation |
| Q57273088 | Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability |
| Q37034707 | Antimicrobial peptides in human skin disease. |
| Q34684398 | Antimicrobial peptides in the oral environment: expression and function in health and disease. |
| Q37954721 | Antimicrobial peptides: key components of the innate immune system |
| Q51145739 | Antiplasmodial activity of tick defensins in a mouse model of malaria. |
| Q43639700 | Artificial beta-defensin based on a minimal defensin template. |
| Q33686462 | Artificial disulfide-rich peptide scaffolds with precisely defined disulfide patterns and a minimized number of isomers. |
| Q37689800 | Avian antimicrobial host defense peptides: from biology to therapeutic applications. |
| Q28271109 | Avian defensins |
| Q52682316 | Beta-Defensin 2 and 3 Promote Bacterial Clearance of Pseudomonas aeruginosa by Inhibiting Macrophage Autophagy through Downregulation of Early Growth Response Gene-1 and c-FOS. |
| Q37844632 | Beta-defensins: what are they really doing in the oral cavity? |
| Q38162043 | Bovine β-defensin gene family: opportunities to improve animal health? |
| Q30151971 | Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections |
| Q93045538 | Characterization of host defense molecules in the human pancreas |
| Q46460554 | Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii). |
| Q58771119 | Characterization of the β-defensin genes in giant panda |
| Q35794672 | Chemokine receptors and leukocyte trafficking in the mucosal immune system. |
| Q39203205 | Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines |
| Q34660888 | Combining flagellin and human β-defensin-3 to combat bacterial infections |
| Q38788790 | Control of the Physical and Antimicrobial Skin Barrier by an IL-31-IL-1 Signaling Network. |
| Q42165308 | Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens |
| Q24648026 | Crystal structures of human alpha-defensins HNP4, HD5, and HD6 |
| Q57476688 | Cysteines and Disulfide-Bridged Macrocyclic Mimics of Teixobactin Analogues and Their Antibacterial Activity Evaluation against Methicillin-Resistant (MRSA) |
| Q33903419 | Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6. |
| Q34579734 | Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. |
| Q36488755 | Defensins in innate antiviral immunity |
| Q95840985 | Defensins: A Double-Edged Sword in Host Immunity |
| Q38201011 | Defensins: antifungal lessons from eukaryotes |
| Q91861171 | Defining the mobility range of a hinge-type connection using molecular dynamics and metadynamics |
| Q45303710 | Defining the native disulfide topology in the somatomedin B domain of human vitronectin |
| Q47979721 | Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris |
| Q31015139 | Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data |
| Q57046321 | Did cis- and trans-defensins derive from a common ancestor? |
| Q30397736 | Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study |
| Q36332730 | Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients. |
| Q37247514 | Disulfide cross-linking influences symbiotic activities of nodule peptide NCR247. |
| Q55604491 | Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? |
| Q35006475 | Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins |
| Q30179403 | Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins |
| Q53281868 | Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity. |
| Q37780272 | Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity |
| Q42625994 | Equine beta-defensin-1: full-length cDNA sequence and tissue expression |
| Q24793732 | Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate |
| Q37053063 | Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction |
| Q24648799 | Functional structure of the somatomedin B domain of vitronectin |
| Q54368244 | Host defense (Antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes. |
| Q35010044 | Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? |
| Q36276925 | Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. |
| Q33753961 | Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells. |
| Q88954037 | Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion |
| Q27649353 | Human Macrophage Inflammatory Protein 3 : Protein and Peptide Nuclear Magnetic Resonance Solution Structures, Dimerization, Dynamics, and Anti-Infective Properties |
| Q42089675 | Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins |
| Q37053332 | Human antimicrobial proteins effectors of innate immunity |
| Q50335870 | Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. |
| Q34737252 | Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules |
| Q41837033 | Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo |
| Q42013622 | Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant |
| Q41500846 | Human beta-defensin-3 producing cells in septic implant loosening. |
| Q34124118 | Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. |
| Q30032656 | Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus |
| Q34727874 | Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins |
| Q42285768 | Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons |
| Q27310039 | Human β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid |
| Q39496522 | Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF |
| Q35580348 | Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity |
| Q54342786 | Human β-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model. |
| Q37318727 | Human β-defensin-3 structure motifs that are important in CXCR4 antagonism |
| Q28509274 | Identification and Biological Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3 |
| Q36010308 | Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity |
| Q24644482 | Impact of pro segments on the folding and function of human neutrophil alpha-defensins |
| Q49852449 | Importance of phosphoinositide binding by human β-defensin 3 for Akt-dependent cytokine induction |
| Q38227832 | Importance of β-defensins in sperm function |
| Q42937024 | In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases |
| Q54365857 | In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus. |
| Q36954965 | Induction of group A Streptococcus virulence by a human antimicrobial peptide |
| Q33619244 | Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization |
| Q91178592 | Integrated solid-state NMR and molecular dynamics modeling determines membrane insertion of human β-defensin analog |
| Q41149978 | Kinetic and thermodynamic studies reveal chemokine homologues CC11 and CC24 with an almost identical tertiary structure have different folding pathways |
| Q50070363 | Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c mice. |
| Q33795132 | Macrocyclic Antimicrobial Peptides Engineered from ω-Conotoxin |
| Q36134856 | Mammalian defensins in the antimicrobial immune response |
| Q40478628 | Membrane damage and repair in primary monocytes exposed to human β-defensin-3 |
| Q35027911 | Membrane disruptive antimicrobial activities of human β-defensin-3 analogs |
| Q50072115 | Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity. |
| Q58746619 | Modification of the surface of titanium with multifunctional chimeric peptides to prevent biofilm formation via inhibition of initial colonizers |
| Q38824103 | Modulation of host defense peptide-mediated human mast cell activation by LPS. |
| Q40846156 | Modulation of neutrophil apoptosis by antimicrobial peptides |
| Q44976434 | Molecular and functional characterization of bovine beta-defensin-1. |
| Q42606648 | Molecular diversity of the antimicrobial domain of beta-defensin 3 and homologous peptides |
| Q33905204 | Multidimensional signatures in antimicrobial peptides |
| Q52368484 | Multifaceted immune functions of human defensins and underlying mechanisms. |
| Q34098551 | Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities |
| Q39709081 | Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements |
| Q35950558 | Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds |
| Q36288808 | Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions |
| Q33876601 | Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity |
| Q46313866 | Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. |
| Q58107788 | Overexpressing ovotransferrin and avian β-defensin-3 improves antimicrobial capacity of chickens and poultry products |
| Q33815422 | Paneth cell α-defensins in enteric innate immunity |
| Q33533544 | Peptide fragments of a beta-defensin derivative with potent bactericidal activity |
| Q40487333 | Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. |
| Q21266611 | Polymorphic segmental duplications at 8p23.1 challenge the determination of individual defensin gene repertoires and the assembly of a contiguous human reference sequence |
| Q41916247 | Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering |
| Q24310770 | Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense |
| Q33780738 | Psd1 Effects on Candida albicans Planktonic Cells and Biofilms |
| Q35998473 | Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins |
| Q39766457 | Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. |
| Q97653000 | Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus |
| Q34418988 | Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. |
| Q26864737 | Revealing the properties of plant defensins through dynamics |
| Q43958057 | Salt-resistant homodimeric bactenecin, a cathelicidin-derived antimicrobial peptide |
| Q52656373 | Simulating the antimicrobial mechanism of human β-defensin-3 with coarse-grained molecular dynamics. |
| Q28116444 | Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells |
| Q36492362 | Structural perspectives on antimicrobial chemokines |
| Q45022873 | Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity |
| Q24676176 | Structure-dependent functional properties of human defensin 5 |
| Q36128939 | Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges |
| Q54452869 | Studies of the biological properties of human beta-defensin 1. |
| Q45156268 | Synthesis of cyclic peptides through an intramolecular amide bond rearrangement |
| Q92156594 | Synthetic Human β Defensin-3-C15 Peptide in Endodontics: Potential Therapeutic Agent in Streptococcus gordonii Lipoprotein-Stimulated Human Dental Pulp-Derived Cells |
| Q38919751 | Targeting bactoprenol-coupled cell envelope precursors |
| Q85282087 | The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant |
| Q95840995 | The Antimicrobial Peptide Human Beta-Defensin 2 Inhibits Biofilm Production of Pseudomonas aeruginosa Without Compromising Metabolic Activity |
| Q27676502 | The Cyclic Cystine Ladder in -Defensins Is Important for Structure and Stability, but Not Antibacterial Activity |
| Q37023132 | The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro |
| Q44221211 | The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes |
| Q33836880 | The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids |
| Q36592239 | The changing of the guard: Molecular diversity and rapid evolution of beta-defensins |
| Q36508686 | The co-evolution of host cationic antimicrobial peptides and microbial resistance |
| Q36798766 | The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability |
| Q37209150 | The drosomycin multigene family: three-disulfide variants from Drosophila takahashii possess antibacterial activity |
| Q37017370 | The role of antimicrobial peptides at the ocular surface |
| Q39903794 | The role of human beta-defensin-2 in bone |
| Q37361213 | The roles of antimicrobial peptides in innate host defense |
| Q50092750 | The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens |
| Q43470518 | The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells |
| Q28828268 | Thermodynamic instability of viral proteins is a pathogen-associated molecular pattern targeted by human defensins |
| Q24652382 | Through the looking glass, mechanistic insights from enantiomeric human defensins |
| Q34122347 | Topology of the disulfide bonds in the antiviral lectin scytovirin |
| Q27644561 | Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs |
| Q47557198 | Towards the Application of Human Defensins as Antivirals |
| Q45883008 | Transplantation of BMSCs expressing hVEGF165 /hBD3 promotes wound healing in rats with combined radiation-wound injury |
| Q80501633 | Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A |
| Q45023232 | Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides |
| Q34462507 | Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? |
| Q35173769 | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? |
| Q51972625 | beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. |
| Q37968296 | α-Defensins in human innate immunity |
| Q37996291 | β-Defensins: multifunctional modulators of infection, inflammation and more? |
Search more.